EQUINE

Legup Program

PRESTIGE® 5 + WNV

(EEE, WEE, EIV, EHV-1, EHV-4, WNV killed, Tetanus Toxoid)

Overview | Indications | Administration | Resources

PRESTIGE® 5 + WNV

Product Description

PRESTIGE flu-containing equine vaccines provide the most updated flu strains available.

Product Label
  • Multiple antigen combination reduces need for several injections
  • Formulated to minimize reactions and maximize protection
  • Available in 10-dose vials and 1 mL single-dose prefilled syringes
  • Tetanus, WNV, EEE and WEE are core vaccinations recommended by the AAEP vaccine guidelines and are indicated in the immunization program for all horses each year
  • Provides 6 months of protection against EIV
  • A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07, West Nile virus – flavivirus chimera and tetanus toxoid
  • Advanced filtration process through the Antigen Purification System (APS™)
  • Exceptional safety profile with the exclusive Havlogen® Adjuvant

Indications

This product has been shown effective for the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis (EEE and WEE) viruses, equine influenza virus (EIV), equine herpesvirus type 1 (EHV-1), equine herpesvirus type 4 (EHV-4), tetanus and West Nile Virus. Duration of immunity has been shown at 6 months for EIV. Duration of immunity for Eastern and Western encephalomyelitis viruses, EHV-1, EHV-4, tetanus and West Nile Virus has not been established. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov.

This product has been shown to be effective against virus shedding of EIV, EHV-1 and EHV-4, and encephalitis and viremia caused by West Nile Virus.

Administration

Dose

For pregnant mares administer a 2 mL dose intramuscularly in the 5th, 7th and 9th months of pregnancy. Three doses are essential for primary immunization. Maiden and barren mares housed or pastured with pregnant mares should be vaccinated on the same schedule. For primary vaccination against respiratory disease administer three 2 mL doses intramuscularly at 4 to 6 week intervals. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. For more information on revaccination frequency, consult your veterinarian.

Caution

Store at 2°-8°C (35°-46°F). Shake well before using. Use entire contents when first opened. Do not mix with other products. This product has not been tested in pregnant animals. Do not vaccinate within 21 days before slaughter. Inject deep into the muscle only. Local reactions may occur at the injection sites in vaccinates, and most of these reactions resolve in 3 to 7 days following vaccination. Systemic reactions may also occur in animals following vaccination. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.

ANTIBIOTIC: Gentamicin.

PRESERVATIVE: Thimerosal.

FOR ANIMAL USE ONLY

PRESTIGE® EQUIRAB®

Resources

Learn more about the updated line of PRESTIGE vaccines.

Find PDFs to download on technical, bulletins, product updates, vaccinations, programs, outbreaks and other useful information.

Additional Resources